Latest Cash Flow News

EQ Resources Limited reported a record quarterly tungsten concentrate production of 33,249 mtu, driven by operational excellence at its Saloro mine and strategic acquisitions including Tungsten Metals Group Ltd. Despite challenges at Mt Carbine due to low rainfall, the company secured significant funding and is poised for growth.

IODM Limited reported a decline in cash reserves to $461,000 for the December quarter, while projecting revenue growth through new university client onboarding in the UK and North America.

IMEXHS Limited reported a robust 34% increase in FY24 revenue to $26.5 million, driven by new contracts in Colombia and Peru that boosted its Annual Recurring Revenue to $30 million. Despite a slight EBITDA shortfall due to a bad debt expense, the company highlighted operational improvements and strengthened its regional footprint.

Uscom Limited reports a 56% increase in cash on hand to $2.17 million for Q2 2024, driven by strategic moves in China and new product regulatory approvals.

Golden Horse Minerals Ltd posted a CAD 413,000 net cash outflow from operating activities in the December 2024 quarter, while maintaining a robust cash balance of CAD 13.37 million. The company’s cash burn reflects ongoing exploration and evaluation investments.

Coda Minerals has significantly enhanced the economic outlook of its Elizabeth Creek Copper-Cobalt Project, with a pre-tax NPV7 rising to $1.18 billion and a post-tax NPV7 increase of 57% to $802 million. The company also secured $5.1 million in fresh capital to accelerate exploration and drilling activities in 2025.

Mastermyne Group Limited reported a 14% rise in EBITDA to $4.1 million for FY25 Q2, even as revenue fell 10% due to operational disruptions at Anglo American’s Grosvenor mine. The company secured key contract extensions and maintained a strong cash position, positioning itself for growth amid sector uncertainties.

Pacific Current Group reports a 6.1% increase in total Funds Under Management to A$30 billion as of December 31, 2024, despite a decline in USD-denominated assets and exits from two boutique managers.

Careteq Limited reports solid progress in integrating its Embedded Health Solutions with HMR Referrals, alongside a 14% revenue increase and improved cash flow in Q2 FY25.

Prophecy International has inked a three-year global reseller agreement with US SIEM leader Securonix, aiming to generate over $1 million in new annual recurring revenue within the first year.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.

TerraCom Limited reported resilient coal sales of 1.6 million tonnes for the December quarter despite weather disruptions, while advancing its Moorlands Thermal Coal Project and maintaining a fully franked dividend.